Jakko van Ingen

63PUBLICATIONS
88CO-AUTHORS
Medical bacteriologyMedical mycologyNanotoxicology, health and safetyComputational physiologyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Jun 13, 2026
Exposure to azithromycin and the effect of co-administration of rifampicin in patients with non-tuberculous mycobacterial disease.

|May 25, 2026
Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions.

|Mar 31, 2026
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial.

Charles L Daley, Jakko van Ingen, James D Chalmers

|Jan 22, 2026
Clinical Characteristics and Management of Non-Tuberculous Mycobacterial Skin and Soft Tissue Infections: A Retrospective Cohort Study.

Wouter Peeters, Chang van Lier, Jakko van Ingen

|Dec 24, 2025
Survey on therapeutic drug monitoring practices for nontuberculous mycobacterial infections: an NTMnet/ESGMYC collaborative study.

Victor Næstholt Dahl, Nicole Maranchick, Jakko van Ingen

|Dec 10, 2025
Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?

Arthur Lemson, Esmee van der Pol, Jakko van Ingen

Pageof 11

Frequent Collaborators

11 joint publications

Wouter Hoefsloot

8 joint publications

Mike Marvin Ruth

6 joint publications

Ralf Stemkens

6 joint publications

Dirk Wagner